This compound is an Fmoc-protected amino acid derivative featuring a tert-butoxycarbonyl (Boc)-protected aminoethoxy substituent on the phenyl ring. It is used as a building block in solid-phase peptide synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1013883-02-7
N-Fmoc-4-(tert-butoxycarbonylmethoxy)-L-phenylalanine
pharmaceutical intermediate
Fmoc-O-tert-butyl-D-tyrosine
pharmaceutical intermediate
Fmoc-O-tert-butyl-L-tyrosine
pharmaceutical intermediate
(2S)-2-[[2-(9H-fluoren-9-ylmethoxycarbonylamino)acetyl]amino]-5-[[2-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonyl]hydrazinyl]methylideneamino]pentanoic acid
pharmaceutical intermediate
4-Oxazolidinecarboxylic acid, 3-((2S)-2-(((9H-fluoren-9-ylmethoxy)carbonyl)amino)-1-oxo-3-phenylpropyl)-2,2,5-trimethyl-, (4S,5R)-
pharmaceutical intermediate
1-(Fmoc-amino)cyclopropanecarboxylic acid
pharmaceutical intermediate
2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(7-methyl-1H-indol-2-yl)propanoic acid
pharmaceutical intermediate
Zinc iodide
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[4-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethoxy]phenyl]propanoic acid
BQFZEDGXSYOUAW-MHZLTWQESA-N
CC(C)(C)OC(=O)NCCOC1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
—